This Obesity Drug Stock Surges 60% on Phase 3 News
A notable fund sold millions of dollars’ worth of shares as this obesity drug stock jumped on Phase 3 momentum. Here’...
Identify situations where TRI provides a fuller view of performance than a price index, especially when dividends and compounding matter to total returns.
26,863 articlesA notable fund sold millions of dollars’ worth of shares as this obesity drug stock jumped on Phase 3 momentum. Here’...
A fresh market screen identifies five high-yield dividend stocks trading under $10, presenting a potential income lif...
Bitcoin faces a fresh test as five straight weeks of spot ETF withdrawals drain billions. Miners liquidate, bids thin...
Biotech investors woke up to a sharp move in this crispr therapeutics stock after CRISPR Therapeutics announced new d...
XRP faces a divided market: ETF demand wanes and hodlers split on the near-term fate. The coin sits near a key suppor...
XRP trades near $1.05 as on-chain MVRV metrics flash a rare setup. A breakout above stubborn resistance could unlock ...
Bitcoin stirred market drama as it neared 69,000, triggering massive short liquidations. Across ethereum solana short...
Major cryptocurrencies hold support as regulatory and macro headlines shape momentum. The crypto price prediction tod...
Ripple vaults onto CNBC’s disruptor list, while XRP trades in a tight range. The token hovered around $1.35 as market...
XRP slid below $1.10 while XRP ETFs showed back-to-back days with no net inflows, sparking questions about whether bi...
Structure Therapeutics stock has surged after a major hedge fund increased its stake. This article breaks down what s...
Oil prices edge higher around $99 a barrel on March 12, 2026, as markets assess supply constraints and demand trends....